Atossa Therapeutics
ATOS
#10409
Rank
A$28.14 M
Marketcap
A$2.82
Share price
-10.59%
Change (1 day)
126.70%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of September 2025 : A$70.77 Million

According to Atossa Therapeutics's latest financial reports the company has A$70.77 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.11 B-13.98%
2023-12-31$A$0.13 B-22.93%
2022-12-31$A$0.17 B-9.02%
2021-12-31$A$0.19 B439.27%
2020-12-31$A$35.33 M88.03%
2019-12-31$A$18.79 M50.34%
2018-12-31$A$12.49 M40.63%
2017-12-31$A$8.88 M106.86%
2016-12-31$A$4.29 M-16.35%
2015-12-31$A$5.13 M-55.74%
2014-12-31$A$11.6 M-2.35%
2013-12-31$A$11.88 M138.65%
2012-12-31$A$4.98 M227.4%
2011-12-31$A$1.52 M-281.39%
2010-12-31$-A$0.84 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$115.41 B 162,966.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$11.01 B 15,456.27%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$12.43 B 17,465.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A$1.17 B 1,564.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A$61.69 M-12.83%๐Ÿ‡บ๐Ÿ‡ธ USA